These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36406896)

  • 21. Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration.
    Lakhani L; Alasfar S; Bhalla A; Aala A; Rosenberg A; Ostrander D; Schollenberger MD; Brennan DC; Lipson EJ
    Transplant Direct; 2021 Feb; 7(2):e656. PubMed ID: 33490381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data.
    Sayah D; Weigt SS; Ramsey A; Ardehali A; Golden J; Ross DJ
    Transplant Direct; 2020 Oct; 6(10):e608. PubMed ID: 33062841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
    Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
    Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection.
    Keller MB; Tian X; Jang MK; Meda R; Charya A; Ozisik D; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Apr; 43(4):563-570. PubMed ID: 37972825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
    Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
    Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why Cell-Free DNA Can Be a "Game Changer" for Lung Allograft Monitoring for Rejection and Infection.
    Rosenheck JP; Keller BC; Fehringer G; Demko ZP; Bohrade SM; Ross DJ
    Curr Pulmonol Rep; 2022; 11(3):75-85. PubMed ID: 35910533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor-derived Cell-free DNA Evaluation in Pediatric Heart Transplant Recipients: A Single-center 12-mo Experience.
    Sorbini M; Aidala E; Carradori T; Vallone FE; Togliatto GM; Caorsi C; Mansouri M; Burlo P; Vaisitti T; Amoroso A; Deaglio S; Pace Napoleone C
    Transplant Direct; 2024 Oct; 10(10):e1689. PubMed ID: 39301559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.
    Huang E; Haas M; Gillespie M; Sethi S; Peng A; Najjar R; Vo A; Jordan SC
    Transplantation; 2023 Jan; 107(1):274-282. PubMed ID: 35913057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.
    Sigdel TK; Archila FA; Constantin T; Prins SA; Liberto J; Damm I; Towfighi P; Navarro S; Kirkizlar E; Demko ZP; Ryan A; Sigurjonsson S; Sarwal RD; Hseish SC; Chan-On C; Zimmermann B; Billings PR; Moshkevich S; Sarwal MM
    J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30583588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between lung allograft rejection and infection using donor-derived cell-free DNA and pathogen detection by metagenomic next-generation sequencing.
    Ju C; Wang L; Xu P; Wang X; Xiang D; Xu Y; Xu X; Chen R; He J
    Heliyon; 2023 Nov; 9(11):e22274. PubMed ID: 38053854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Intrapatient Tacrolimus Variability and Increased Cell-Free DNA in Kidney Transplant Recipients.
    Kopfman M; Brokhof M; Patel S; Fu D; Olaitan O
    Prog Transplant; 2024 Dec; 34(4):204-210. PubMed ID: 39376164
    [No Abstract]   [Full Text] [Related]  

  • 37. A rapid noninvasive assay for the detection of renal transplant injury.
    Sigdel TK; Vitalone MJ; Tran TQ; Dai H; Hsieh SC; Salvatierra O; Sarwal MM
    Transplantation; 2013 Jul; 96(1):97-101. PubMed ID: 23756769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management.
    Qazi Y; Patel A; Fajardo M; McCormick S; Fehringer G; Ahmed E; Malhotra M; Demko ZP; Billings PR; Tabriziani H; Gauthier P
    Transplant Proc; 2021 Dec; 53(10):2866-2872. PubMed ID: 34774309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Donor-derived Cell-free DNA to Inform Tapering of Immunosuppression Therapy in Kidney Transplant Recipients: An Observational Study.
    Osuchukwu G; Trevino A; McCormick S; Kaur N; Prigmore B; Al Haj Baddar N; Bloom MS; Demko Z; Gauthier P
    Transplant Direct; 2024 Apr; 10(4):e1610. PubMed ID: 38481964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single center study investigating the clinical association of donor-derived cell-free DNA with acute outcomes in lung transplantation.
    Noda K; Snyder ME; Xu Q; Peters D; McDyer JF; Zeevi A; Sanchez PG
    Front Transplant; 2023; 2():1339814. PubMed ID: 38993874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.